Mutagenesis studies of the human erythropoietin receptor. Establishment of structure-function relationships.
Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding. We employed both random and site-specific mutagenesis to determine the function of amino acid residues in the extracellular domain (referred to as EPO binding protein, EBP) of the EPOR. Residues were chosen for site-specific alanine substitution based on the results of the random mutagenesis or on their homology to residues that are conserved or have been reported to be involved in ligand binding in other receptors of the cytokine receptor family. Site-specific mutants were expressed in Escherichia coli as soluble EBP and analyzed for EPO binding in several different assay formats. In addition, selected mutant proteins were expressed as full-length EPOR on the surface of COS cells and analyzed for 125I-EPO binding in receptor binding assays. Using these methods, we have identified residues that appear to be involved in EPO binding as well as other residues, most of which are conserved in receptors of the cytokine receptor family, that appear to be necessary for the proper folding and/or stability of the EPOR. We present correlations between these mutagenesis data and the recently solved crystal structure of the EBP with a peptide ligand.
Barbone
F P
FP
The R. W. Johnson Pharmaceutical Research Institute, Drug Discovery Research, Raritan, New Jersey 08869, USA. Barbonef@PRIUS.JNJ.com
Middleton
S A
SA
Johnson
D L
DL
McMahon
F J
FJ
Tullai
J
J
Gruninger
R H
RH
Schilling
A E
AE
Jolliffe
L K
LK
Mulcahy
L S
LS
D000595:Amino Acid Sequence; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D017467:Receptors, Erythropoietin / Q000235:genetics*; D017421:Sequence Analysis; D013329:Structure-Activity Relationship
D017467:Receptors, Erythropoietin